NCT00764894

Brief Summary

The purpose of this study is to evaluate the use and efficacy of the Encore Foundation Knee System in a group of 200 patients for whom data has already been collected.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2007

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 30, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 2, 2008

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2011

Completed
Last Updated

February 9, 2011

Status Verified

February 1, 2011

Enrollment Period

3.3 years

First QC Date

September 30, 2008

Last Update Submit

February 8, 2011

Conditions

Outcome Measures

Primary Outcomes (1)

  • The use and efficacy of the Encore Foundation Knee System

    2 year

Study Arms (1)

Foundation Knee

Retrospective data collection on 510(k) approved device

Device: Foundation Knee

Interventions

Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis who received a primary Foundation Knee replacement and is willing to participate in the study.

Foundation Knee

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals who meet the indications for use of the Foundation Knee device AND who meet the inclusion/exclusion criteria

You may qualify if:

  • Have knee joint disease related to one or more of the following
  • osteoarthritis
  • post-traumatic arthritis
  • inflammatory tissue disorders
  • arthritis secondary to other diseases
  • Avascular necrosis of the femoral condyles;
  • Skeletal maturity
  • Less than 70 on the Knee Society Score (rating score)
  • Sufficient bone stock, as judged by radiographs, to support primary knee implant
  • Sufficient collateral ligaments to support the device, as judged by physician during stability testing (varus/valgus and flexion/extension) and less than 45 degree varus/valgus deformity and/or 90 degree flexion contracture
  • Patient is likely to be available for evaluation for the duration of the study
  • Able and willing to sign the informed consent and follow study procedures
  • Patient is not pregnant
  • No infection present
  • No known materials sensitivity

You may not qualify if:

  • Skeletal immaturity
  • Greater than or equal to 70 on preoperative Knee Society Score (Rating Score)
  • Post-patellectomy
  • Insufficient bone quality which may affect implant stability
  • Insufficient collateral ligaments, as judged by the physician. Greater than 45 degree varus/valgus deformity and/or 90 degree flexion contracture.
  • Neurological conditions that might hinder patient's ability to follow study procedures (i.e., any that restrict physical activities such as Parkinson's Disease, Multiple Sclerosis, previous stroke which affects lower extremity)
  • Mental conditions that may interfere with ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the patient cannot understand the informed consent process, global dementia, prior strokes that interfere with the patient's cognitive abilities, senile dementia, and Alzheimer's Disease)
  • Prisoners
  • Conditions that place excessive demand on the implant (i.e. Charcot's joints, muscle deficiencies, refusal to modify postoperative physical activities, skeletal immaturity)
  • Patient is pregnant
  • Infection present
  • Materials sensitivity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hussamy Orthopedics

Vero Beach, Florida, 32960, United States

Location

Related Links

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Omar Hussamy, M.D.

    Hussamy Orthopedics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 30, 2008

First Posted

October 2, 2008

Study Start

October 1, 2007

Primary Completion

February 1, 2011

Study Completion

February 1, 2011

Last Updated

February 9, 2011

Record last verified: 2011-02

Locations